News Focus
News Focus
icon url

DewDiligence

06/18/15 10:48 AM

#192675 RE: DewDiligence #192670

MNTA’s PR on favorable CAFC ruling:

http://finance.yahoo.com/news/momenta-pharmaceuticals-announces-cafc-decision-143714364.html

An immediate launch of Glatopa (generic Copaxone) should now follow, although the PR doesn’t actually announce the launch.
icon url

vinmantoo

06/18/15 11:52 AM

#192684 RE: DewDiligence #192670

{{NVS/MNTA are now free to lunch Glatopa (generic Copaxone)}}

I think they should order lobster and some fine champagne to wash it down with! ;)
icon url

zipjet

06/18/15 5:30 PM

#192706 RE: DewDiligence #192670

Is Glatopa substitutable?

How big is the remaining market at the 20mg dose?



icon url

DewDiligence

06/18/15 7:19 PM

#192712 RE: DewDiligence #192670

NVS/MNTA launch Glatopa (generic 20mg Copaxone):

http://finance.yahoo.com/news/momenta-pharmaceuticals-announces-launch-glatopa-210000503.html

MNTA gets an immediate $10M milestone payment from NVS and is eligible to receive up to $120M in anniversary-based and sales-based milestones.